Johnson DE - Search Results

1

Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents.

Antoku K, Liu Z, Johnson DE. Antoku K, et al. Among authors: johnson de. Leukemia. 1997 Oct;11(10):1665-72. doi: 10.1038/sj.leu.2400805. Leukemia. 1997. PMID: 9324287

2

Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family.

Dou QP, An B, Antoku K, Johnson DE. Dou QP, et al. Among authors: johnson de. J Cell Biochem. 1997 Mar 15;64(4):586-94. J Cell Biochem. 1997. PMID: 9093908

3

IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells.

Antoku K, Liu Z, Johnson DE. Antoku K, et al. Among authors: johnson de. Leukemia. 1998 May;12(5):682-9. doi: 10.1038/sj.leu.2400992. Leukemia. 1998. PMID: 9593265

4

Bcl-2- and CrmA-inhibitable dephosphorylation and cleavage of retinoblastoma protein during etoposide-induced apoptosis.

An B, Johnson DE, Jin JR, Antoku K, Dou QP. An B, et al. Among authors: johnson de. Int J Mol Med. 1998 Jan;1(1):131-6. doi: 10.3892/ijmm.1.1.131. Int J Mol Med. 1998. PMID: 9852210

5

Analysis of the role of conserved cysteine residues in the bcl-2 oncoprotein.

Maser RS, Antoku K, Scully WJ Jr, Cho RL, Johnson DE. Maser RS, et al. Among authors: johnson de. Biochem Biophys Res Commun. 2000 Oct 14;277(1):171-8. doi: 10.1006/bbrc.2000.3652. Biochem Biophys Res Commun. 2000. PMID: 11027659

6

Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein.

Antoku K, Maser RS, Scully WJ Jr, Delach SM, Johnson DE. Antoku K, et al. Among authors: johnson de. Biochem Biophys Res Commun. 2001 Sep 7;286(5):1003-10. doi: 10.1006/bbrc.2001.5512. Biochem Biophys Res Commun. 2001. PMID: 11527400

7

Noncaspase proteases in apoptosis.

Johnson DE. Johnson DE. Leukemia. 2000 Sep;14(9):1695-703. doi: 10.1038/sj.leu.2401879. Leukemia. 2000. PMID: 10995018 Review.

8

Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L)and XIAP in the prolonged survival of monocytic cells.

Miranda MB, Dyer KF, Grandis JR, Johnson DE. Miranda MB, et al. Among authors: johnson de. Leukemia. 2003 Feb;17(2):390-400. doi: 10.1038/sj.leu.2402779. Leukemia. 2003. PMID: 12592339

9

Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family.

Shangary S, Johnson DE. Shangary S, et al. Among authors: johnson de. Leukemia. 2003 Aug;17(8):1470-81. doi: 10.1038/sj.leu.2403029. Leukemia. 2003. PMID: 12886234 Review.

10

Programmed cell death regulation: basic mechanisms and therapeutic opportunities.

Johnson DE. Johnson DE. Leukemia. 2000 Aug;14(8):1340-4. doi: 10.1038/sj.leu.2401849. Leukemia. 2000. PMID: 10942226 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,449 results

Search Page

Filters